StockNews.AI
AGEN
StockNews.AI
175 days

Agenus to Provide Corporate Update and Fourth Quarter & Full Year 2024 Financial Report

1. Agenus to release Q4 and full-year 2024 financial results before market open. 2. Executives will host an 8:30 a.m. ET conference call for a corporate update.

Earnings
-1.58%Current Return
VS
-0.39%S&P 500
$3.1602/25 08:57 AM EDTEvent Start
$3.1102/26 03:45 PM EDTLatest Updated
2m saved
Insight
Article

FAQ

Why Neutral?

Earnings releases introduce volatility; outcome ambiguity keeps expectations balanced. Historical biotech earnings events show immediate moves but later stabilization.

How important is it?

Earnings announcements are pivotal corporate events likely to cause significant short-term price changes despite uncertain results.

Why Short Term?

Earnings events drive immediate price action; long-term trends require additional data, as seen in past biotech reports.

Related Companies

BIIBREGNAMGN
LEXINGTON, Mass.--(BUSINESS WIRE)--Agenus Inc. (“Agenus”) (Nasdaq: AGEN), a leader in developing novel immunological agents to treat various cancers, today announced the Company will release its fourth quarter and year end 2024 financial results before the market opens on Tuesday, March 11th. Agenus executives will host a conference call and webcast at 8:30 a.m. ET that morning to discuss the results and provide a corporate update. Conference Call: To access dial-in numbers, please register her.

Related News